Pharmacy World & Science

, Volume 32, Issue 3, pp 329–333 | Cite as

Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacy

  • Juraporn PongwecharakEmail author
  • Tarakamon Treeranurat
Short Research Report


Objectives To identify subjects with pre-hypertension and elevated cardiovascular risk factors in a community pharmacy and to assess their readiness to adopt lifestyle changes. Setting An accredited community pharmacy in Songkla province, Thailand.Method Subjects aged ≥ 35 years old and reporting no hypertension or other cardiovascular disease were included. Blood pressure was measured using the Microlife BP 3AC1-1. Those with pre-hypertension or hypertension defined by the JNC 7, and reporting no diabetes and/or dyslipidemia, were checked for blood glucose and/or total cholesterol with the Accutrend GCT monitor. Other risk factors were collected. Their readiness to adopt healthy lifestyles was evaluated. Main outcome measure The prevalence of pre-hypertension and elevated cardiovascular risk factors. Results 350 subjects met the study criteria. Approximately 36 and 29% were pre-hypertensive and hypertensive, respectively. Two of these had blood glucose > 200 mg/dl but about 47% had total cholesterol > 200 mg/dl. Most common modifiable cardiovascular risks were inadequate exercise and elevated body mass index (~52% each). Almost 40% were ready to adopt healthy lifestyles within 1–6 months. Conclusion Subjects at risk for hypertension and cardiovascular disease can be identified by community pharmacists, with the use of point-of-care devices and careful interview.


Blood pressure Cardiovascular risks Community pharmacy Diabetes Dyslipidemia Hypertension Pharmacist Point-of-care Screening Thailand 



We thank the Samaphan International Co., LTD. and Roche Diagnostics (Thailand) for the supply of Microlife BP 3AC1-1 and Accutrend GCT devices, respectively. Language proof-reading by Prof L.A. Damani is appreciated.


The research project had some financial support from the Faculty of Graduate Study and the Faculty of Pharmaceutical Sciences, Prince of Songkla University.

Conflict of interest statement

The corresponding author provides routine professional service at the study site on a scheduled basis, but was not engaged in the screening process.


  1. 1.
    Aekplakorn W, Abbott-Klafter J, Khonputsa P, Tatsanavivat P, Chongsuvivatwong V, Chariyalertsak S, et al. Prevalence and management of prehypertension and hypertension by geographic regions of Thailand: the Third National Health Examination Survey. J Hypertens. 2008;26:191–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Kshisagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006;119:133–41.CrossRefGoogle Scholar
  3. 3.
    Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, et al. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–16.CrossRefPubMedGoogle Scholar
  4. 4.
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.CrossRefPubMedGoogle Scholar
  5. 5.
    Zimmerman GL, Olsen CG, Bosworth MF. A ‘Stages of Change’ approach to helping patients change behavior. Am Fam Physician. 2000;61:1409–16.PubMedGoogle Scholar
  6. 6.
    Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc. 2003;43:50–5.CrossRefGoogle Scholar
  7. 7.
    Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high risk individuals. J Am Pharm Assoc. 2006;46:370–7.CrossRefGoogle Scholar
  8. 8.
    Ministry of Public Health. Chapter 5 Health status and health problems of Thai subjects. In: Thailand health profile report 2005–2007. Accessed 18 Nov 2009.
  9. 9.
    Kadowaki S, Okamura T, Hozawa A, Kadowaki T, Kadota A, Murakami Y, et al. Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80. Diabetologia. 2008;51:575–82.CrossRefPubMedGoogle Scholar
  10. 10.
    Yamwong S. Full research report: development of a cardiovascular risk assessment tool. Health Research Network. National Health Foundation. 2005. Accessed 18 Nov 2009 (Thai language).

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Department of Clinical Pharmacy, Faculty of Pharmaceutical SciencesPrince of Songkla UniversitySongkhlaThailand

Personalised recommendations